Rxivist logo

SARS-CoV-2 Exploits Sexually Dimorphic and Adaptive IFN and TNFa Signaling to Gain Entry into Alveolar Epithelium

By Filippo Giancotti, Yan Wang, Sreeharsha Gurrapu, Hong Chen, Sara Laudato, Emily Caggiano, Yan Jiang, Hsiang-Hsi Ling

Posted 23 Jul 2021
bioRxiv DOI: 10.1101/2021.07.23.453505

Infection of the alveolar epithelium constitutes a bottleneck in the progression of COVID-19 to SARS presumably due to the paucity of viral entry receptors in alveolar epithelial type 1 and 2 cells. We have found that the male alveolar epithelial cells express twice as many ACE2 and TMPRSS2 entry receptors as the female ones. Intriguingly, IFN and TNF- signaling are preferentially active in male alveolar cells and induce binding of the cognate transcription factors to the promoters and lung-active enhancers of ACE2 and TMPRSS2. Cotreatment with IFN-I and III dramatically increases expression of the receptors and viral entry in alveolar epithelial cells. TNF and IFN-II, typically overproduced during the cytokine storm, similarly collaborate to induce these events. Whereas JAK inhibitors suppress viral entry induced by IFN-I/III, simultaneous inhibition of IKK/NF-{kappa}B is necessary to block viral entry induced by TNF and IFN II. In addition to explaining the increased incidence of SARS in males, these findings indicate that SARS-Cov-2 hijacks epithelial immune signaling to promote infection of the alveolar epithelium and suggest that JAK inhibitors, singly and in combination with NF-KB inhibitors, may exhibit efficacy in preventing or treating COVID-19 SARS.

Download data

  • Downloaded 271 times
  • Download rankings, all-time:
    • Site-wide: 128,464
    • In immunology: 3,876
  • Year to date:
    • Site-wide: 52,850
  • Since beginning of last month:
    • Site-wide: 18,386

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide